Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Randomised Controlled Trial: Partial Hydrolysation of Casein Protein in Milk Decreases Gastrointestinal Symptoms in Subjects with Functional Gastrointestinal Disorders.

Tytuł:
Randomised Controlled Trial: Partial Hydrolysation of Casein Protein in Milk Decreases Gastrointestinal Symptoms in Subjects with Functional Gastrointestinal Disorders.
Autorzy:
Laatikainen R; Booston Oy Ltd., Viikinkaari 6, FI-00790 Helsinki, Finland.
Salmenkari H; Pharmacology, Medical Faculty, University of Helsinki, P.O. Box 63, FI-00014 Helsinki, Finland.
Sibakov T; Valio Ltd., R&D, P.O. Box 30, FI-00039 Valio, Finland.
Vapaatalo H; Pharmacology, Medical Faculty, University of Helsinki, P.O. Box 63, FI-00014 Helsinki, Finland.
Turpeinen A; Valio Ltd., R&D, P.O. Box 30, FI-00039 Valio, Finland.
Źródło:
Nutrients [Nutrients] 2020 Jul 18; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 18.
Typ publikacji:
Journal Article; Randomized Controlled Trial
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI Publishing
MeSH Terms:
Milk*
Surveys and Questionnaires*
Abdominal Pain/*prevention & control
Caseins/*administration & dosage
Flatulence/*prevention & control
Gastrointestinal Diseases/*complications
Heartburn/*prevention & control
Protein Hydrolysates/*administration & dosage
Symptom Assessment/*methods
Abdominal Pain/etiology ; Adult ; Animals ; Cross-Over Studies ; Female ; Flatulence/etiology ; Gastrointestinal Diseases/physiopathology ; Heartburn/etiology ; Humans ; Irritable Bowel Syndrome ; Male ; Middle Aged ; Severity of Illness Index ; Symptom Flare Up
References:
J Chromatogr A. 2008 Jun 27;1195(1-2):101-6. (PMID: 18495141)
Digestion. 2001;63(2):108-15. (PMID: 11244249)
Nature. 1970 Aug 15;227(5259):680-5. (PMID: 5432063)
Am J Gastroenterol. 2011 Oct;106(10):1749-59; quiz 1760. (PMID: 21747417)
Neurogastroenterol Motil. 2019 Dec;31(12):e13718. (PMID: 31498961)
Allergy. 1998 Mar;53(3):307-10. (PMID: 9542612)
J Dairy Res. 2016 May;83(2):256-60. (PMID: 27034058)
Ann Fam Med. 2014 Mar-Apr;12(2):134-41. (PMID: 24615309)
Eur J Clin Nutr. 2014 Sep;68(9):994-1000. (PMID: 24986816)
Adv Nutr. 2017 Sep 15;8(5):739-748. (PMID: 28916574)
Proc Nutr Soc. 2017 Aug;76(3):203-212. (PMID: 28629483)
Am J Gastroenterol. 2012 Dec;107(12):1898-906; quiz 1907. (PMID: 22825366)
Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):589-605. (PMID: 29930260)
Gut. 2017 Jul;66(7):1241-1251. (PMID: 26976734)
Clin Exp Immunol. 2007 Mar;147(3):449-55. (PMID: 17302893)
Gastroenterology. 2016 Apr;150(4):875-87.e9. (PMID: 26752109)
Gastroenterology. 2016 Feb 13;:. (PMID: 27144634)
J Dairy Res. 2003 May;70(2):175-9. (PMID: 12800871)
Am J Gastroenterol. 2013 May;108(5):634-41. (PMID: 23644955)
Scand J Gastroenterol. 1983 Oct;18(7):865-70. (PMID: 6689563)
Gut. 2017 Aug;66(8):1517-1527. (PMID: 28592442)
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402. (PMID: 9146781)
J Gastrointestin Liver Dis. 2019 Dec 09;28(4):463-472. (PMID: 31826052)
Contributed Indexing:
Keywords: IBS; bloating; casein; functional gastrointestinal disorder; hydrolysation; inflammation; milk
Substance Nomenclature:
0 (Caseins)
0 (Protein Hydrolysates)
Entry Date(s):
Date Created: 20200726 Date Completed: 20210315 Latest Revision: 20210315
Update Code:
20240104
PubMed Central ID:
PMC7400865
DOI:
10.3390/nu12072140
PMID:
32708428
Czasopismo naukowe
Unspecific gastrointestinal symptoms associated with milk consumption are common. In addition to lactose, also other components of milk may be involved. We studied whether the partial hydrolysation of milk proteins would affect gastrointestinal symptoms in subjects with functional gastrointestinal disorders. In a randomised, placebo-controlled crossover intervention, subjects ( n = 41) were given ordinary or hydrolysed high-protein, lactose-free milkshakes (500 mL, 50 g protein) to be consumed daily for ten days. After a washout period of ten days, the other product was consumed for another ten days. Gastrointestinal symptoms were recorded daily during the study periods, and a validated irritable bowel syndrome-symptom severity scale (IBS-SSS) questionnaire was completed at the beginning of the study and at the end of both study periods. Blood and urine samples were analysed for markers of inflammation, intestinal permeability and immune activation. Both the IBS-SSS score ( p = 0.001) and total symptom score reported daily ( p = 0.002) were significantly reduced when participants consumed the hydrolysed product. Less bloating was reported during both study periods when compared with the baseline ( p < 0.01 for both groups). Flatulence ( p = 0.01) and heartburn ( p = 0.03) decreased when consuming the hydrolysed product but not when drinking the control product. No significant differences in the levels of inflammatory markers (tumor necrosis factor alpha, TNF-α and interleukin 6, IL-6), intestinal permeability (fatty acid binding protein 2, FABP2) or immune activation (1-methylhistamine) were detected between the treatment periods. The results suggest that the partial hydrolysation of milk proteins (mainly casein) reduces subjective symptoms to some extent in subjects with functional gastrointestinal disorders. The mechanism remains to be resolved.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies